Schizophrenia Research Forum - A Catalyst for Creative Thinking
Home Profile Membership/Get Newsletter Log In Contact Us
 For Patients & Families
What's New
Recent Updates
SRF Papers
Current Papers
Search All Papers
Search Comments
News
Research News
Conference News
Forums
Current Hypotheses
Idea Lab
Online Discussions
Virtual Conferences
Interviews
Resources
What We Know
SchizophreniaGene
Animal Models
Drugs in Trials
Research Tools
Grants
Jobs
Conferences
Journals
Community Calendar
General Information
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
History
SRF Team
Advisory Board
Support Us
How to Cite
Fan (E)Mail
The Schizophrenia Research Forum web site is sponsored by the Brain and Behavior Research Foundation and was created with funding from the U.S. National Institute of Mental Health.
Research News
back to News Search
     
The DISC1 Switch in Neurodevelopment

22 April 2011. Disrupted in schizophrenia 1 (DISC1), a major susceptibility factor for schizophrenia and other mental disorders, acts as a switch between neuronal proliferation and migration during brain development, according to a study appearing online April 6 in Nature. Led by Akira Sawa of Johns Hopkins University School of Medicine in Baltimore, Maryland, the study finds that the phosphorylation state of DISC1 flips the switch: when unphosphorylated at a certain site, DISC1 promotes neuron birth through Wnt signaling, and when phosphorylated, DISC1 aggregates with centrosomal proteins, which are instrumental for getting new neurons to move on to their proper locations in the brain.

The study unites previous findings of a role for DISC1 in both proliferation and migration. Reduced neuronal proliferation by neural progenitors has been reported in mice with a DISC1 mutation modeled after the translocation found in the Scottish family that originally led researchers to DISC1 (Shen et al., 2008), and DISC1 promotes new neuron birth through Wnt signaling—a pathway involved in the proliferation of a number of cell types (see SRF related news story). In addition, Sawa and his team have shown that DISC1 binds to Bardet-Biedel syndrome (BBS) proteins and recruits them to the centrosome, an event that readies new neurons for migration (see SRF related news story).

The new work illustrates how DISC1 can work through distinct pathways during the course of brain development. Combined with another study that explores the neuroanatomical consequences of point mutations to DISC1 from Albert Wong at the University of Toronto in Canada, these findings support the idea that DISC1 is critical for proper neurodevelopment, and that problems with the protein could leave a brain predisposed to mental illness.

Focus on phosphorylation
Suspecting that a phosphorylation-mediated modification could regulate whether DISC1 spurred proliferation or migration, first author Koko Ishizuka and colleagues began by simply asking whether human DISC1 protein could be phosphorylated. Indeed, it could, at three different sites, two of which were conserved in mouse DISC1: serine 170 (S170) and serine 58 (S58). Using site-directed mutagenesis, the researchers developed a "phospho-dead" version of the protein that was incapable of being phosphorylated at the S170 site, or a "phospho-mimic" that was constitutively phosphorylated at this site. They found that the phospho-dead DISC1 protein did not bind as well to BBS1 and BBS4 proteins as wild-type DISC1 did under conditions that safeguard phosphorylation. In contrast, the phospho-mimic DISC1 readily bound to BBS1, and in mouse cortical neurons, this resulted in correct localization of BBS1 to the centrosome. Mutations to the S58 site did not affect this interaction, suggesting that phosphorylation specifically at the S170 site is critical for migration.

On the other hand, DISC1 needed to be unphosphorylated at S170 to promote Wnt pathway signaling and spur cell proliferation. When DISC1 levels were knocked down in a non-neural cell line that reports Wnt pathway activity, the phospho-dead DISC1 could rescue Wnt signaling, but not the phospho-mimic DISC1 (as read out by β-catenin and cyclin D1 activity, downstream events in the Wnt pathway). An in vivo version of this experiment using in utero gene transfer in mice to introduce Wnt signaling constructs and RNAi to knock down endogenous DISC1 found the same requirement for unphosphorylated DISC1 to revive Wnt pathway activity in neurons.

Field test in the developing brain
These results suggest that, once phosphorylated at S170, DISC1 switches its role from proliferation to migration, and prompted the researchers to look for evidence of such a change in the developing mouse brain. Using an antibody that recognizes DISC1 only when it is phosphorylated at S170, they found higher antibody staining levels at E18, when migration is prominent, than at E14, when proliferation predominates. This staining was not found in the birthplace of new neurons, but rather in regions where only migrating neurons pass through.

Next, the researchers used co-immunoprecipitation to ask which proteins in mouse brain extracts normally bind to phosphorylated DISC1 at different time points in development. Between E14, when cell birth abounds, and E18, when migration is afoot, they found an increase in the amount of BBS1 protein bound by phosphorylated DISC1, and a similar sized decrease in the amount of bound glycogen synthase kinase 3β (GSK3β)—a key player in Wnt signaling. This same pattern emerged when progenitor cells and post-mitotic neurons were isolated from mouse brain, with post-mitotic neurons exhibiting increased levels of phosphorylated DISC1 at S170, increased BBS1 binding, and decreased affinity for GSK3β compared to progenitor cells.

Finally, when they knocked down DISC1 in embryos using in utero gene transfer, Ishizuka and colleagues could rescue proliferation at E13 by co-injecting phospho-dead or wild-type DISC1, whereas phospho-mimic DISC1 did not work. Conversely, co-injecting the phospho-mimic or wild-type DISC1 at E15 rescued migration, returning the number of migrating cells to normal, but the phospho-dead DISC1 did not. Based on their results, the authors propose that DISC1 unphosphorylated at S170 binds tightly to GSK3β to promote cell proliferation. Later in this model, when DISC1 is somehow phosphorylated at this site, DISC1 dissociates from GSK3β and shuttles BBS1 to the centrosome, triggering migration.

Point mutations point to neurodevelopment
This dual role for DISC1 is reinforced by Wong's study, appearing on March 2 in the Journal of Neuroscience, which explores how two missense point mutations—Q31L and L100P—of DISC1 in mice alter brain anatomy. Though not modeled after human disease-related variants, the two point mutations result in behaviors reminiscent of either depression or schizophrenia (see SRF related news story). In both mutant mouse lines, first author Frankie Lee and colleagues examined the cortex and found decreases in neuron number and neurogenesis—indicators of disturbed proliferation—as well as altered neuron distributions, suggesting that neurons were not migrating correctly compared to wild-type littermate controls. The neurons themselves had shorter dendrites and decreased spine densities than did neurons from wild-type mice, which suggest defects in connectivity. Despite the different behaviors in the two mouse lines, their neuroanatomical findings were largely similar and mimic some of the findings from postmortem brain tissue from individuals with schizophrenia, such as decreased neuron and spine densities.

Together, the new studies present a nuanced view of DISC1 function, with slight changes to DISC1, such as phosphorylation state having significant and widespread consequences in the brain. This calls for careful examination of even subtle modifications of DISC1—not just the major disruption that put it on the radar in the first place—to fully understand DISC1 function in health and in mental illness.—Michele Solis.

References:
Ishizuka K, Kamiya A, Oh EC, Kanki H, Seshadri S, Robinson JF, Murdoch H, Dunlop AJ, Kubo KI, Furukori K, Huang B, Zeledon M, Hayashi-Takagi A, Okano H, Nakajima K, Houslay MD, Katsanis N, Sawa A. DISC1-dependent switch from progenitor proliferation to migration in the developing cortex. Nature. 2011 Apr 6. Abstract

Lee FH, Fadel MP, Preston-Maher K, Cordes SP, Clapcote SJ, Price DJ, Roder JC, Wong AH. Disc1 point mutations in mice affect development of the cerebral cortex. J Neurosci. 2011 Mar 2;31(9):3197-206. Abstract

 
Comments on News and Primary Papers
Primary Papers: Disc1 point mutations in mice affect development of the cerebral cortex.

Comment by:  Atsushi Kamiya
Submitted 2 May 2011 Posted 2 May 2011

In this paper, Lee et al. characterized DISC1 mutant mice, animals with ENU-induced mutation of Q31L and L100P, by systematic histological examinations. These animals had been previously reported to show behavioral abnormalities relevant to major mental disorders, such as schizophrenia and major depression, by Roder and Clapcote (Clapcote et al., 2007). The authors found decreased cell proliferation, altered neuronal distribution, as well as impaired dendritic growth and reduction of spine density in pyramidal neurons, all phenotypes observed in the cerebral cortex. As the authors described, these abnormal cellular architectures had been previously reported in the other DISC1 animal models, including studies using RNAi approaches (Kamiya et al., 2005; Li et al., 2007; Kvajo et al., 2008; Pletnikov et al., 2008;   Read more


View all comments by Atsushi Kamiya

Comment by:  Albert H. C. Wong
Submitted 13 May 2011 Posted 13 May 2011

This recent and important paper by Sawa's group adds another layer to the complex story of DISC1 function in neurodevelopment. Their findings clarify and integrate two streams of research implicating DISC1 in both neuron proliferation and migration. The identification of the S170 phosphorylation site also raises the exciting possibility that pharmacological strategies targeted at this phosphorylation-dependent switch might be useful in correcting or preventing mental illness-related problems with brain development. It would be interesting in this context to explore whether disease-associated DISC1 gene variants in humans affect DISC1 phosphorylation, and the subsequent balance between neuron proliferation and migration.

I agree with Atsushi Kamiya that further work is needed to understand which of the many effects of DISC1 perturbation are specific to human psychiatric disease phenotypes. Again, from a treatment perspective, it is vital to know which cellular abnormality underlies the most debilitating symptoms so that new treatments can be screened for effects on these...  Read more


View all comments by Albert H. C. Wong
Comments on Related News
Related News: New Spin on DISC1—Mouse Mutation Impairs Behavior

Comment by:  Akira Sawa, SRF Advisor
Submitted 8 May 2007 Posted 8 May 2007

This is outstanding work reporting DISC1 genetically engineered mice. Thus far, one type of DISC1 mutant mouse has been reported, by Gogos and colleagues (Koike et al., 2006).

There are two remarkable points in this work. First, of most importance, John Roder and Steve Clapcote have been very successful in using mice with ENU-induced mutations for their questions. Due to the complexity of the DISC1 gene and isoforms, several groups, including ours, have tried but not succeeded in generating knockout mice. However, Roder and Clapcote found alternative mice that could be used in testing our main hypothesis. I believe that the majority of the success in this work is on this particular point. Indeed, to explore animal models for other susceptibility genes for major mental illnesses, this approach should be considered.

Second, it is very interesting that different mutations in the same gene display different types of phenotypes. I appreciate the excellence in the extensive behavioral assays in this work.

Although we need...  Read more


View all comments by Akira Sawa

Related News: New Spin on DISC1—Mouse Mutation Impairs Behavior

Comment by:  Christopher Ross
Submitted 8 May 2007 Posted 8 May 2007

This paper demonstrates that mutations in DISC1 can alter mouse behavior, brain structure, and biochemistry, consistent with the idea that DISC1 is related to major psychiatric disorders. This is already an important result. But more strikingly, the authors’ interpretation is that one mutation (L100P) causes a phenotype similar to schizophrenia, while the other mutation (Q31L) results in a phenotype similar to affective disorder.

There are a number of caveats that need to be considered. No patients with equivalent mutations have been identified. The behavioral tests have only a hypothesized or empiric relevance to behavior in the human illnesses. DISC1 itself, while a very strong candidate gene, is still not fully validated, and the best evidence for its role in schizophrenia still arises from the single large pedigree in Scotland.

Despite these caveats, I believe this paper is potentially a major advance. The authors’ interpretations are provocative, and could have far-reaching implications for understanding of the biological bases of psychiatric diseases. The...  Read more


View all comments by Christopher Ross

Related News: New Spin on DISC1—Mouse Mutation Impairs Behavior

Comment by:  Nick Brandon (Disclosure)
Submitted 8 May 2007 Posted 8 May 2007

Mutant Mice Bring Further Excitement to the DISC1-PDE4 Arena
DISC1 continues to ride a wave of optimism as we look for real breakthroughs in the molecular events underlying major psychiatric disorders including schizophrenia, bipolar, and depression. In 2005, its fortunes became entwined with those of the phosphodiesterase PDE4B as they were shown to functionally and physically interact (Millar et al., 2005). Evidence linking PDE4B to depression has been known for some time, but in the wake of the DISC1 finding, its link to schizophrenia has hardened (Siuciak et al., 2007; Menniti et al., 2006; Pickard et al., 2007).

The Roder and Porteous labs have come together to produce a fantastic paper describing two ENU mutant mice lines with specific mutations in the N-terminus of DISC1. Luck was on their side as the mutations seem to have a direct impact on the interaction with the PDE4B. Furthermore, the two lines look to have...  Read more


View all comments by Nick Brandon

Related News: DISC1: A Matter of Life or Death for Neural Progenitors

Comment by:  Khaled Rahman
Submitted 26 March 2009 Posted 26 March 2009

Mao and colleagues present an impressive body of work implicating GSK3β/β-catenin signaling in the function of Disc1. However, several key experimental controls are missing that detract from the impact of their study, and it is unclear whether this function of Disc1 among its many others is the critical link between the t(1;11) translocation and psychopathology in the Scottish family.

The results of Mao et al. suggest that acute knockdown of Disc1 in embryonic brain causes premature exit from the proliferative cell cycle and premature differentiation into neurons. In fact, they observe fewer GFP+ cells in the VZ/SVZ and greater GFP+ cells within the cortical plate. This is in contrast to the study by Kamiya et al. (2005), in which they find that knocking down Disc1 caused greater retention of cells in the VZ/SVZ and fewer in the cortical plate, suggesting retarded migration. Although the timing of electroporation (E13 vs. E14.5) and examination (E15 vs. P2) differed between the two studies, these results are not...  Read more


View all comments by Khaled Rahman

Related News: DISC1: A Matter of Life or Death for Neural Progenitors

Comment by:  Simon Lovestone
Submitted 27 March 2009 Posted 27 March 2009

This is an intriguing paper that builds on a growing body of evidence implicating wnt regulation of GSK3 signaling in psychotic illness (Lovestone et al., 2007).

It is interesting that the authors report that binding of DISC1 to GSK3 results in no change in the inhibitory Ser9 phosphorylation site of GSK3 but a change in Y216 activation site and that this resulted in effects on some but not all GSK3 substrates. This poses a challenge both in terms of understanding the role of GSK3 signaling in schizophrenia and other psychotic disorders and in drug discovery.

The authors cite some of the other evidence for regulation of GSK3 signaling in psychosis, including, for example, the evidence for a role of AKT signaling alteration in schizophrenia and lithium, an inhibitor of GSK3, as a treatment for bipolar disorder. But in both cases, AKT (Cross et al., 1995) and lithium (Jope, 2003), the effect on GSK3 is predominantly via Ser9...  Read more


View all comments by Simon Lovestone

Related News: DISC1: A Matter of Life or Death for Neural Progenitors

Comment by:  Nick Brandon (Disclosure)
Submitted 27 March 2009 Posted 30 March 2009
  I recommend the Primary Papers

Li-huei Tsai and colleagues have identified another pathway in which the candidate gene DISC1 looks to have a critical regulatory role, namely the wnt signaling pathway, in progenitor cell proliferation. In recent years we have seen that DISC1 has a vital role at the centrosome (Kamiya et al., 2005), in cAMP signaling (Millar et al., 2005), and in multiple steps of adult hippocampal neurogenesis (Duan et al., 2007). They have shown a pivotal role for DISC1 in neural progenitor cell proliferation through regulation of GSK3 signaling using a spectacular combination of cellular and in utero manipulations with shRNAs and GSK3 inhibitor compounds. These findings clearly implicate DISC1 in another “druggable” pathway but at this stage do not really identify new approach/targets, except perhaps to confirm that manipulating adult neurogenesis and the wnt pathway holds much potential hope for therapeutics. Perhaps understanding the mechanism of...  Read more


View all comments by Nick Brandon

Related News: DISC1: A Matter of Life or Death for Neural Progenitors

Comment by:  Akira Sawa, SRF Advisor
Submitted 8 April 2009 Posted 8 April 2009

Mao and colleagues’ present outstanding work sheds light on a novel function of DISC1. Because DISC1 is a multifunctional protein, the addition of new functions is not surprising. Thus, for the past several years, the field has focused on how DISC1 can have distinct functions in different cell contexts (for example, progenitor cells vs. postmitotic neurons, or developing cortex vs. adult dentate gyrus). In addition to Mao and colleagues, I understand that several groups, including ours, have obtained preliminary, unpublished evidence that DISC1 regulates progenitor cell proliferation, at least in part via GSK3β. Thus, I am very supportive of this new observation.

If there might be a missing point in this paper, it is unclear whether suppression of GSK3β occurs in several different biological contexts in brain in vivo. In other words, it is uncertain whether DISC1’s actions on GSK3β are constitutive or context-dependent. How can we reconcile differential roles for DISC1 in progenitor cells in contrast to postmitotic neurons? We have already obtained a...  Read more


View all comments by Akira Sawa
Submit a Comment on this News Article
Make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Affiliation  
Country or Territory  
*Login Email Address  
*Confirm Email Address  
*Password  
*Confirm Password  
Remember my Login and Password?  
Get SRF newsletter with recent commentary?  
 
Enter the code as it is shown below:
This code helps prevent automated registrations.

I recommend the Primary Papers

Please note: A member needs to be both registered and logged in to submit a comment.

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


SRF News
SRF Comments
Text Size
Reset Text Size
Email this pageEmail this page

Share/Bookmark
Copyright © 2005- 2013 Schizophrenia Research Forum Privacy Policy Disclaimer Disclosure Copyright